Month: April 2019

Thursday, April 11, 2019

Peak Serum, Inc. has entered into a strategic partnership with Japanese biotechnology product distributor, Vita, Inc. Vita, a distributor and marketer of biotechnology products, represents trusted suppliers from various countries and prides itself on reducing the risk of purchasing raw materials for use in research and manufacturing.

“Vita is trusted by life science companies around the globe and Peak Serum is honored to partner with such a credible distributor,” said Tom Kutrubes, President and CEO of Peak Serum, Inc. “Through this partnership, we hope to continue to expand our reach, providing even more quality Fetal Bovine Serum (FBS) to laboratories worldwide.”

Vita represents suppliers of biotechnology products from the U.S., Canada, Germany, England, Sweden, Italy, New Zealand, China, India and other countries. The company handles diverse products that range from antibodies and ELISA kits, to primary cell-based products and specialized cell culture media, as well as sophisticated scientific instruments and niche services.

In addition to Vita, Peak Serum has existing partnerships with a wide range of distributors including Stratech Scientific and Dae Myung Science CO., LTD. “Through our collaboration with trusted distributors, Peak Serum can continue to further its reach and ultimately fulfill our mission of progressing research that is important to finding cures for diseases and illnesses that affect the world.”  

Tuesday, April 9, 2019

Peak Serum, Inc. is currently seeking applications for its annual Cares for Cures Grant. Through this initiative, a biological research lab is selected to receive a Fetal Bovine Serum donation from Peak Serum. Click here to fill out the grant form for consideration. Labs of any size are encouraged to apply and the donation recipient will be notified by email.

“Our mission with Peak Serum’s Cares for Cures program is to give back to the research community that continues to support Peak Serum,” said Tom Kutrubes, President and CEO of Peak Serum, Inc. “It is my belief that it is our responsibility as a company to go the extra mile in supporting research initiatives can change the world.”

Dr. Wendy Huang of the UC San Diego School of Medicine was awarded the first Cares for Cures Grant in 2017. Her team’s research impacts inflammatory bowel conditions, breast, prostate and intestinal cancers and other inflammation-related diseases.

From the Department of Medicine at Washington University School of Medicine, Dr. Russell Pachynski was the second recipient of the Cares for Cures Grant in 2018. His groundbreaking research is very unique and encompasses both clinical (prostate) and laboratory (leukocyte) research.

“To give back and partner with labs to make cures for diseases become a reality is a very high priority for Peak Serum,” said Kutrubes. “We are not just another serum company. We care about our customers and hope to show our true compassion through the annual Cares for Cures Grant.”